TITLE

ISL1 Protein Transduction Promotes Cardiomyocyte Differentiation from Human Embryonic Stem Cells

AUTHOR(S)
Fonoudi, Hananeh; Yeganeh, Meghdad; Fattahi, Faranak; Ghazizadeh, Zaniar; Rassouli, Hassan; Alikhani, Mehdi; Mojarad, Bahareh Adhami; Baharvand, Hossein; Salekdeh, Ghasem Hosseini; Aghdami, Nasser
PUB. DATE
January 2013
SOURCE
PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Human embryonic stem cells (hESCs) have the potential to provide an unlimited source of cardiomyocytes, which are invaluable resources for drug or toxicology screening, medical research, and cell therapy. Currently a number of obstacles exist such as the insufficient efficiency of differentiation protocols, which should be overcome before hESCderived cardiomyocytes can be used for clinical applications. Although the differentiation efficiency can be improved by the genetic manipulation of hESCs to over-express cardiac-specific transcription factors, these differentiated cells are not safe enough to be applied in cell therapy. Protein transduction has been demonstrated as an alternative approach for increasing the efficiency of hESCs differentiation toward cardiomyocytes. Methods: We present an efficient protocol for the differentiation of hESCs in suspension by direct introduction of a LIM homeodomain transcription factor, Islet1 (ISL1) recombinant protein into the cells. Results: We found that the highest beating clusters were derived by continuous treatment of hESCs with 40 mg/ml recombinant ISL1 protein during days 1-8 after the initiation of differentiation. The treatment resulted in up to a 3-fold increase in the number of beating areas. In addition, the number of cells that expressed cardiac specific markers (cTnT, CONNEXIN 43, ACTININ, and GATA4) doubled. This protocol was also reproducible for another hESC line. Conclusions: This study has presented a new, efficient, and reproducible procedure for cardiomyocytes differentiation. Our results will pave the way for scaled up and controlled differentiation of hESCs to be used for biomedical applications in a bioreactor culture system.
ACCESSION #
85384389

 

Related Articles

  • Price to pay. Hall, Amy Laura // Christian Century;6/1/2004, Vol. 121 Issue 11, p8 

    Discusses the moral implication of embryonic stem cell research in the U.S. Draft from the United Methodist Bioethics Task Force on the issue of human cloning; Distinctions proposed for the evaluation of embryonic stem cell research; Reasons for opposing the use of such research for medical...

  • iPS and ES Cells: Do Both Roads Lead to Rome? Ng, Valerie Y.; Choo, Andre B. H. // Open Stem Cell Journal;2010 Special Issue, p8 

    The seminal report from Takahashi and Yamanka in 2006 describing the reprogramming of somatic cells to induced pluripotent stem (iPS) cells [1] marked the beginning of a new field of research, resulting in hundreds of publications in a short 3 years. Among other things, the promise of iPS cells...

  • Selling Out for Science. Guterl, Fred; Cunningham, Jaime; Raymond, Joan; Brownell, Ginanne // Newsweek (Pacific Edition);11/8/2004 (Pacific Edition), Vol. 144 Issue 19, p46 

    Focuses on the debate over stem cells in the United States. Claim that some scientists have exaggerated stem cells' potential for cures; Reference to a proposition in California that would give $3 billion to human embryonic stem cell research; Research conducted by Hans Kierstead of the...

  • Selling Out for Science. Guterl, Fred; Cunningham, Jaime; Raymond, Joan; Brownell, Ginanne // Newsweek (Atlantic Edition);11/8/2004 (Atlantic Edition), Vol. 144 Issue 19, p54 

    Focuses on the debate over stem cells in the United States. Claim that some scientists have exaggerated stem cells' potential for cures; Reference to a proposition in California that would give $3 billion to human embryonic stem cell research; Research conducted by Hans Kierstead of the...

  • The Bioethics of Human Pluripotent Stem Cells: Will Induced Pluripotent Stem Cells End the Debate? Watt, Julia C.; Kobayashi, Nao R. // Open Stem Cell Journal;2010 Special Issue, p18 

    The ethical debate surrounding human pluripotent stem (PS) cell research is mainly due to use of human embryonic stem (ES) cells. It has been suggested by many that human induced pluripotent stem (iPS) cells would end the debate due to their non-embryonic origin. This review examines the ethical...

  • Suspension Culture of Undifferentiated Human Embryonic and Induced Pluripotent Stem Cells. Amit, Michal; Chebath, Judith; Margulets, Victoria; Laevsky, Ilana; Miropolsky, Yael; Shariki, Kohava; Peri, Meital; Blais, Idit; Slutsky, Guy; Revel, Michel; Itskovitz-Eldor, Joseph // Stem Cell Reviews & Reports;Jun2010, Vol. 6 Issue 2, p248 

    Alongside their contribution to research, human embryonic stem cells (hESC) may also prove valuable for cell-based therapies. Traditionally, these cells have been grown in adhesion culture either with or without feeder cells, allowing for their continuous growth as undifferentiated cells....

  • Attachment of Embryonic Stem Cells-derived Cardiomyocytes in CultiSpher-S Microcarriers by using Spinner Flask. Akasha, Abdulrhman. A.; Elouz, Abdurrahim A. // Jordan Journal of Biological Sciences;Jun2012, Vol. 5 Issue 2, p135 

    Embryonic Stem (ES) cells have the ability to differentiate under in vitro conditions into cardiomyocytes. A transgenic α-myosin heavy chain (α-MHC+) ES cell line was generated, exhibiting puromycin resistance and expressing enhanced green fluorescent protein (EGFP) under control of the...

  • 3-ingredient cocktail makes heart cells from stem cells. Breindl, Anette // Medical Device Daily;5/7/2009, Vol. 13 Issue 87, p2 

    This article discusses a study published in the April 26, 2009 online edition of "Nature" which defined the factors necessary to turn embryonic stem cells into beating heart muscle cells. Both GATA4 and TBX4 are cardiac-specific transcription factors, while BAF60c is a chromatin remodeling...

  • Prometheus, Pandora, and the Myths of Cloning. Van Gend, David // Human Life Review;Summer/Fall2006, Vol. 32 Issue 3/4, p15 

    The author discusses issues related to the implications of stem-cell research and cloning for the medical field in the U.S. According to the author, cloning is redundant because research on using embryonic stem cells to develop treatments has encountered problems where adult stem-cell research...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics